ArticleBMC cancer2020

UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study.

Hideki Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.